Tag: Nordisk
Profit increases by 51 percent: Novo Nordisk numbers soar thanks to weight loss products
Profit increases by 51 percent Novo Nordisk numbers soar thanks to weight loss products January 31, 2024, 12:26 p.m Listen to article This audio version was artificially generated. More info…
Novo Nordisk: prospects raised for the flagship product Wegovy
(AOF) – Patients should take the weight loss drug Wegovy much longer than older treatments. This was declared yesterday by Lars Fruergaard Jorgensen, general director of the Danish laboratory Novo…
Novo Nordisk: Oddo BHF confirms its recommendation
(CercleFinance.com) – Oddo BHF maintains its outperform rating on Novo Nordisk shares with an unchanged price target of 800 DKK. The analyst recalls that Novo Nordisk communicated yesterday, during the…
Novo Nordisk: Positive trial in type 2 diabetes
(CercleFinance.com) – Novo Nordisk announces the first results of a phase 3a trial comparing the effectiveness and safety of once-weekly IcoSema to insulin glargine U100 and insulin aspart (injected 2…
Novo Nordisk: Birth of a stock market star in 2023
(CercleFinance.com) – The Danish pharmaceutical group Novo Nordisk became the largest European capitalization this year, stealing its crown from the luxury giant, the French LVMH. The laboratory now has a…
Novo Nordisk: birth of a stock market star in 2023
(CercleFinance.com) – The Danish pharmaceutical group Novo Nordisk became the largest European capitalization this year, stealing its crown from the luxury giant, the French LVMH. The laboratory now has a…
Novo Nordisk heavyweight of the European rating
(AOF) – Novo Nordisk ends the year as the largest European capitalization. The title of the diabetes treatment specialist jumped almost 50% to 700.50 Norwegian crowns. Novo Nordisk owes its…
Novo Nordisk will invest $6 billion to boost Wegovy production
Published on 11/10/2023 at 2:13 p.m. Photo credit © Reuters by Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN…
Novo Nordisk: More precise results around Wegovy
(CercleFinance.com) – Novo Nordisk on Monday unveiled more detailed results from its trial on the cardiovascular benefits of its anti-obesity drug Wegovy, which caused a stir this summer. The Danish…
Novo Nordisk in good shape after better-than-expected third-quarter results
(AOF) – Novo Nordisk (+3.84% to 714.10 Danish crowns) is in good shape today on the Copenhagen stock exchange after record results. The pharmaceutical group, the largest European capitalization since…
GE HealthCare: Collaboration agreement with Novo Nordisk
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
GE HealthCare: collaboration agreement with Novo Nordisk
(CercleFinance.com) – The American GE HealthCare announced Thursday evening the signing of a collaboration agreement with the Danish laboratory Novo Nordisk with a view to developing an ultrasound treatment for…